February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

July 02, 2024

Black Docs Lacking Amid Growing Attacks on Diversity Programs

Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.

KFF Health News

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

May 01, 2024

Practice Management Strategies: The Sunk Cost Fallacy

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

Join Dr. Mace L. Rothenberg on a journey through history and future innovations in science and medicine at the Museum of Medicine and Biomedical Discovery, a captivating and interactive experience designed to engage visitors of all ages.

The ASCO Post

June 21, 2024

Judge Rules HHS Online Tracking Bulletin Unlawful

Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.

Conexiant

June 26, 2024

PDS Health Marks Three Decades of Excellence with Over 1,000 Practices Nationwide

PDS Health Celebrates 30th Anniversary

Inside Dentistry

May 01, 2024

Coding and Compliance: A 10-Step Guide for ICD-10 Success

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

December 05, 2024

Two Insulin List Prices Cut by Over 70%

The list prices of its insulin drug Fiasp will be reduced by 75%, while the list prices of its Tresiba insulin will be reduced by 72.2%.

Reuters